On Aug. 29, 2025, the National Institutes of Health (NIH) announced it had awarded Duke University $69 million to accelerate how scientific discoveries translate to better health for all. The seven-year grant will help support the Duke Clinical and Translational Science Institute (CTSI) as it builds and sustains “Trustworthy Partnerships to Improve Health Through Translational Science.”

Duke received one of the original 12 grants in 2006 under the NIH’s Clinical and Translational Science Award (CTSA) program, with previous renewals of $47 million in 2013 and $60 million in 2018.

The CTSA program supports a national network of more than 60 medical institutions that offer expertise, resources, and partnerships at the national and local levels to improve the health of individuals and communities. The program also nurtures the field of translational science (bench-to-bedside research) through education, training, and career support at all levels.

This new award builds on nearly two decades of work advancing clinical and translational research locally, regionally, and nationally, and includes a strong partnership with North Carolina Central University (NCCU).

The collaboration has launched pilot research partnerships, a junior faculty development program, and many other initiatives related to workforce development, community engagement, and research.